CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 128 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2015 | $209,000 | -31.0% | 8,300 | -23.9% | 0.00% | 0.0% |
Q1 2015 | $303,000 | +12.6% | 10,900 | -28.3% | 0.00% | 0.0% |
Q1 2014 | $269,000 | -26.9% | 15,200 | 0.0% | 0.00% | -50.0% |
Q4 2013 | $368,000 | -38.6% | 15,200 | -10.1% | 0.00% | -33.3% |
Q3 2013 | $599,000 | +470.5% | 16,900 | +152.2% | 0.00% | – |
Q2 2013 | $105,000 | – | 6,702 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |